|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| C12N 5/20 |
| (11) | Number of the document | 2301576 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10180748.5 |
| Date of filing the European patent application | 2004-11-08 | |
| (97) | Date of publication of the European application | 2011-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 557621 P | 2004-03-29 | US | |
| 557620 P | 2004-03-29 | US | |
| 557622 P | 2004-03-29 | US | |
| 842011 | 2004-05-07 | US | |
| 982357 | 2004-11-05 | US |
| (72) |
Williams, Marna, US
Tso, J. Yun, US
Landolfi, Nicolas F., US
Liu, Gao, US
|
| (73) |
Abbott Biotherapeutics Corp.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | Therapeutic use of Anti-CS1 Antibodies |
| Therapeutic use of Anti-CS1 Antibodies |